Clinical trial
Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in…
NCT00139932 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00139932 |
|---|---|
| Title | Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) |
| Official title | A Double-Blind Randomized, Parallel-Group, Multicenter Clinical Study to Compare the Efficacy and Tolerability of Tiotropium Bromide Alone vs. the Co-Administration of Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Collaborators | Integrated Therapeutics Group Industry Novartis |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | formoterol fumarate |
| Enrollment | 255 |
| Start date | Sep 1, 2005 |
| Primary completion | Nov 21, 2006 |
| Completion | Nov 21, 2006 |
| First posted | Aug 31, 2005 |
| Last update posted | Mar 24, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: